torna all'home
chi siamo
cosa ci proponiamo
cosa facciamo
e-mail
progetti
come aiutarci
patologie
letture
biblioteca
eventi

archivio fotografico

International Journal of Health, Culture and Migration

Concerto per l'Etiopia

L'altra faccia di Gaia di Aldo Morrone

Dermatology of Human Mobile Populations

I SISTEMI SANITARI AFFRONTANO LA POVERTÀ

I colori della pelle

 

 
     

International Society of Dermatology - Palm Coast, FL - USA

   
San Gallicano Institute—IRCCS, Rome
Dep. of Preventive Medicine of Migration, Tourism and Tropical Dermatology

   

IISMAS
International Institute of Social, Medical and Anthropological Sciences - Rome

   
       
  First International Congress on    
  DERMATOLOGICAL CARE FOR ALL
“A BASIC HUMAN RIGHT”
   
       
 

Addis Ababa-Mekele (Ethiopia)
November 1 - 4, 2006
Italian Dermatological Hospital of Quihà - Tigray

   
       
       
 Abstracts MYCETOMA AND BOTRYOMYCOSIS: DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND TREATMENT
(Category 21: Infectious Dermatosis)
   
       
  Author: Professor W.P. Daniel Su
Dermatology Department Mayo Clinic, Rochester, MN, USA
Originally from Taiwan, China
   
       
       
 

ABSTRACT


When “grains” (condensed clusters of organisms) are observed in the gross or microscopic specimens, one should consider three main categories: Bacteria-induced Mycetoma, Eumycetoma, and Botryomycosis.
Mycetoma is a tumorous infection of the skin and subcutaneous tissue. It is caused by either actinomycotic bacteria or eumycotic imperfect fungi. The three cardinal features are 1) tumefaction or the appearance of indolent inflammatory nodules and secondary fibrosis, 2) formation of sinus tracts and fistulas that may have the capability of penetrating deep tissue, and 3) the presence of grains or granules in the affected tissue and discharge. Although mycetoma is relatively uncommon,
increasing mobility and an ever-changing demographic picture should heighten our awareness of this disease. Characteristic histopathologic findings and microbiologic identification establish the diagnosis. Consequently, when evaluating what might seem like an ordinary skin or fungal infection, we must widen our suspicion to include mycetoma. Effective treatments for actinomycetoma are available, whereas
eumycetoma often presents a treatment challenge.
Botryomycosis is a chronic, suppurative disease that is often mistaken clinically and histologically as a fungus infection. Actually, it is caused by bacteria.
Staphylococcus aureus is the most common causative organism, but many other bacteria have also been reported, such as Pseudomonas aeruginosa, E. coli, Proteus species, Bacillus species, and so on. If the clinical lesions are small, surgical excision should be considered. Most of the patients will respond to systemic and topical antibiotics.

References

  1. Mehregan DA, Su WPD, Anhalt JP: Cutaneous botryomycosis. J Amer Acad Dermatol 1991; 24: 393-6
  2. McElroy JA, de Almeida Prestes C, Su WPD: Mycetoma: Infection with tumefaction, draining sinuses and “grains”. Cutis 1992; 49: 107-10
  3. Young BA: Mycetoma. J Am Podiatr Med Assoc 2000; 90:81-4
  4. Rigopoulos D: Mycetoma due to actinomycetes: A rare entity in Europe (letter). Int J Dermatol 2000; 39:557-8
  5. Jaffer A, Schanbacher CF, Calobrisi SD, Su WPD.
    Sudden onset of Multiple painful erythematous papules.
    (Botryomycosis). Off Center Fold, Arch Dermatol 2003;
    139: 93-8.
  6. N’diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol. 2006 Feb;45(2):154-7.
   
 Abstracts      
 

 

 

 

 

 

 

 

   
       
       
IISMAS ONLUS - Via Anagnina 325 - 00118 ROMA - Tel.06/86891172